Individual Difference
10
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (10)
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in Humans
Modifying Whey Protein Fortified Drinks and Foods
Investigating the Influence of Age and Saliva Flow on the Perception of Protein Fortified Foods and Beverages
Investigating Consumers Perception and Acceptance of Whey Beverages
Individual and Environmental Risk Factors for Unscheduled Hospitalizations of Elderly People
Evaluating Attitudes Towards Organ Donation in the United States on MTurk
Investigation of the Perception of Protein Fortified Foods and Beverages
The Influence of Fat Perception on Satiety From Consumption of Reduced Fat Snacks
Identifying Neuroimaging Biomarkers, Demographic, Personality and Sensory Factors for Predicting Extreme Pain Responses to Various Experimental Pain Stimulations in Healthy Subjects
Increasing Individualism and Collectivism